Our global sites Open Search About us Our science Our products Investors Sustainability Careers Get in touch Major shareholders Allergy Therapeutics PLC Shareholder services Major shareholders Overview At a glance Financial highlights Investment case Regulatory news Email alert Results, reports and presentations Financial Calendar Share tools Shareholder services AGM information Registrar Details Major shareholders Analyst coverage Electronic communications AIM Rule 26 Corporate governance Investor and Advisor Contacts Share Information The total number of shares issued is 641,480,218 Ordinary Shares of 0.1 pence each. 78.38% of the shares are not in public hands, as at 30 April 2021. Significant Shareholders The following were the significant shareholders as notified to the Company at 30 April 2021: Shareholder name Amount % Holding Abbott Laboratories 240,584,571 37.49 Southern Fox Investments 128,833,783 20.07 SkyGem Acquisition Limited (ZQ Capital) 128,622,798 20.04 River & Mercantile Asset Management 30,350,000 4.73 Director Shareholdings Director name Amount % Holding Manuel Llobet* 3,325,000 0.52 Nick Wykeman* 300,000 0.05 Peter Jensen 270,000 0.04 Tunde Otulana 50,000 0.01 *Executive Director Click for top of the page Linkedin icon Quick links Head office General inquiries Terms and Conditions Privacy Statement Cookies Adverse Event Reporting Modern Slavery and Human Trafficking Statement Gender Pay Gap QCA Code Compliance statement Contact us Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Kingdom Tel +44 (0)1903 844 700 © Allergy Therapeutics 2021. By Emperor Cookie Control